Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/24/2018 |
Start Date: | September 1, 2017 |
End Date: | September 1, 2020 |
Contact: | Evan L Fogel, MD |
Email: | efogel@iu.edu |
Phone: | 317-944-2816 |
The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as
determined by a 30 minute intraductal secretin stimulation test in patients with a low
likelihood of pancreatic pathology and to compare these data to those obtained from our
historical patients with suspected chronic pancreatitis. These will be patients in which
inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde
cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5
day follow-up phone call. Enrollment goal is 36 subjects.
determined by a 30 minute intraductal secretin stimulation test in patients with a low
likelihood of pancreatic pathology and to compare these data to those obtained from our
historical patients with suspected chronic pancreatitis. These will be patients in which
inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde
cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5
day follow-up phone call. Enrollment goal is 36 subjects.
Inclusion Criteria:
1. Male or female patients ≥ 18 years of age referred to Indiana University Health,
University Hospital for ERCP for a biliary indication, at the discretion of the treating MD
(e.g. suspected common bile duct stone, initial post-liver transplant evaluation, suspected
or confirmed cholangiocarcinoma, suspected primary sclerosing cholangitis -- see exclusion
criterion #12)
Exclusion Criteria:
1. Pregnant woman or breast feeding
2. Age <18 years
3. Patient unable to give informed consent
4. Patient with a history of pancreatic surgery
5. Patient with a history of pancreatic cancer
6. Patient with a history of acute or chronic pancreatitis
7. Patient with radiographic evidence of acute or chronic pancreatitis on CT, MRCP, or
EUS
8. Patient with a current or prior history of average daily alcohol consumption of
greater than 60 g per day for more than 2 years
9. Patient with a history of cigarette smoking greater that 20 pack-years
10. Patient with a history of pancreas divisum
11. Evidence of chronic pancreatitis on pancreatogram during ERCP
12. ERCP for an isolated biliary indication with previous biliary sphincterotomy or for
biliary stent exchange, when pancreatic entry should easily be avoided by the
endoscopist.
13. History of allergy or adverse reactions to secretin
We found this trial at
1
site
425 University Blvd.
Indianapolis, Indiana 46202
Indianapolis, Indiana 46202
(317) 274-4591
Phone: 317-944-2816
Indiana University INDIANA UNIVERSITY is a major multi-campus public research institution, grounded in the liberal...
Click here to add this to my saved trials